BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:29 PM
 | 
Oct 01, 2012
 |  BC Extra  |  Clinical News

Synta gains on ganetespib data

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) gained $1.79 (23%) to $9.41 on Monday after reporting additional interim data for ganetespib in 172 patients with stage IIIB/IV non-small cell lung cancer adenocarcinoma in the open-label Phase IIb portion of the Phase IIb/III GALAXY...

Read the full 189 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >